zAngus

$IHL - Impression looking to disrupt the healthcare sector

Long
zAngus Updated   
ASX:IHL   None
$IHL - Impression looking to disrupt the healthcare sector

Receipt of Medicinal Cannabis Licenses from the Department of Health

Impression Healthcare Limited (‘Impression, ‘IHL’ or the ‘Company’) is delighted to announce that it has received the relevant licenses from the Department of Health, Victoria to sell or supply, by wholesale, scheduled cannabinoid substances. Specifically, the licenses includes; Cannabis, Cannabidiol (CBD), Tetrahydrocannabinols (THC) and Dronabinol.


Interesting micro-cap with some sales. Might be one to watch. Announcement today they have their Cannabis licensing approvals from the Aus Government and they do like to be a disruptor with a market direct to consumer type model. Volume looks good with a rising RSI and OBV crossing through its 30 day MA. Has tested some higher prices which is always good. Moving averages all coming down for support.

Impression Healthcare Limited is Australia’s largest home dental impression company and is disrupting the dental devices market by providing consumers with an in-home method to consume laboratory-grade and personalised dental healthcare products at significantly lower prices than those offered by the traditional dental industry. Impression has significantly grown its distribution footprint and increased its revenues by 359% in the 2018 Financial Year. With its own dental laboratory in Victoria, Australia Impression offers best in class teeth protection and helps its customers combat bruxism, snoring, mild to moderate sleep apnoea and teeth discolouration with custom-fitted oral devices.

Impression has also broadened its commitment to disruption in the healthcare sector by pursuing multiple opportunities in the field of medicinal cannabis distribution and development including; a collaboaration agreement with leading US Cannabinoid therapeutics Company, AXIM Biotechnologies Inc; a license agreement for the production and distribution of Dronabinol in the USA, Canada, Australia and New Zealand with Resolution Chemicals Ltd; and an agreement for the distribution of medicinal cannabis oils with a major Canadian manufacturer. Impression will leverage its existing marketing activities to explore opportunities to distribute a range of cannabinoid therapeutic products throughout multiple jurisdicitions.
Comment:
Impression Healthcare scores exclusive supply agreement with corporate dentist 1300SMILES

Nice deal that should help further cashflow their business and give them more momentum on what they can do with the Cannabis licensing approvals.
Comment:
Stock didn't do anything so I exited the trade. Up almost 50% since the start of June though. Hmmm. Will it continue...

Comment:
Popped 7 cents today before a pull back. Worth a good look tomorrow.


NOT TRADING ADVICE. ALWAYS DO YOUR OWN RESEARCH.

FIND TRAILING STOPS: SuperTrail.io

FIND COINS BREAKING OUT: CoinRaces.cc

MY YOUTUBE TRADINGVIEW TIPS AND TRICKS: bit.ly/3kRW08o

MEXC FOR CRYPTO: bit.ly/47QCeNR
Disclaimer

The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.